Storia in 12 fonti

Why Is Moderna Stock Down Today?

The biotech giant posted positive trial results of a cancer vaccine, boosting shares at a record-setting pace before investors pulled back.

Raccontata da

Confronto fonti

6 prospettive sulla stessa storia

AI · summaries

forbes.comStai leggendo1 g fa

Why Is Moderna Stock Down Today?

Moderna's personalized cancer vaccine (mRNA + Keytruda) reduced melanoma recurrence; stock jumped 176%, dropped 25% Thursday on profit-taking. The trial validates mRNA oncology beyond vaccines, marking Moderna's pivot from COVID to profitability—inflection point for biotech-AI investment.

originale

Timeline cronologica

mercoledì 19 agosto 2026·biopharmadive.com
Moderna and Merck cancer vaccine returns ‘landmark’ result in melanoma
At an interim data check, investigators of a key trial found the individualized mRNA treatment kept disease from returning and stopped its spread, sparking a surge in Moderna…
mercoledì 19 agosto 2026·expansion.com
Moderna se dispara m�s del 140% en Bolsa al anunciar resultados positivos en un ensayo cl�nico
Las acciones de las norteamericanas Moderna y Merck (conocida fuera de Estados Unidos y Canad� como MSD) se dispararon este mi�rcoles durante su negociaci�n en el mercado...

Why Is Moderna Stock Down Today?

Confronto fonti

Why Is Moderna Stock Down Today?

Timeline cronologica

Moderna and Merck cancer vaccine returns ‘landmark’ result in melanoma

Moderna se dispara m�s del 140% en Bolsa al anunciar resultados positivos en un ensayo cl�nico

Moderna stock drops 12% after 177% surge: Here’s what Wall Street says about MRNA

For Moderna, cancer vaccine results ease investor skepticism on its future as stock soars

Moderna perde il 25% in borsa: le azioni frenano dopo il massimo storico

Moderna and Merck shares soar on mRNA cancer vaccine

Healthcare Stocks After Hours: Moderna, Merck Cool Following Cancer Trial Gains - Pfizer (NYSE:PFE), Mode

Moderna vola a Wall Street: titolo a +130% dopo i dati sul melanoma - SoldiOnline.it

Why Is BioNTech Stock Surging on Wednesday? - BioNTech (NASDAQ:BNTX)

Dow Jones Top Company Headlines at 1 PM ET: Moderna Shares Double on Success of mRNA Cancer Vaccine | Target ...

Moderna's and Merck's personalized mRNA vaccine shows real promise against deadly skin cancer melanoma in late stage trial and sends stocks…

For Moderna, cancer vaccine results ease investor skepticism on its future as stock soars

Dow Jones Top Company Headlines at 3 PM ET: Moderna Shares More Than Double on Success of mRNA Cancer Vaccine | OpenAI's ...

Moderna and Merck shares soar on mRNA cancer vaccine

Dow Jones Top Company Headlines at 5 PM ET: Moderna Shares More Than Double on Success of mRNA Cancer Vaccine | OpenAI's ...

Moderna Stock Soars on Cancer Vaccine Success

Merck, Moderna Cancer Vaccine Breakthrough Puts 4 ETFs In Focus - Merck & Co (NYSE:MRK)

Health Care Up After Moderna Breakthrough — Health Care Roundup

Why Is Moderna Stock Down Today?

Dow Jones Top Company Headlines at 7 PM ET: Moderna Shares More Than Double on Success of mRNA Cancer Vaccine | OpenAI's ...

MRNA, BULL, BMNR, MSTR, MRK: 5 Trending Stocks Today - Moderna (NASDAQ:MRNA)

Healthcare Stocks After Hours: Moderna, Merck Cool Following Cancer Trial Gains - Pfizer (NYSE:PFE), Mode

Moderna shares double after experimental mRNA cancer treatment passes key test

Recursion, Novavax, Crispr Therapeutics Stocks Slip Premarket After Cancer Therapy Rally - Recursion Phar

Moderna stock drops 12% after 177% surge: Here’s what Wall Street says about MRNA